Home › Kanser sa Pantog › Vermont
Pag-aaral pangklinika para sa Kanser sa Pantog sa Vermont
3 pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa mga site sa Vermont.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT06770582FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- University of Vermont Medical Center, Burlington
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05614739Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Dartmouth Cancer Center - North, Saint Johnsbury
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07061964Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.